Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells.

Author: GaoXiao-pei, GomesIgnatius, KishoreRaj, MalikAsrar B, RajasinghJohnson, SiddiquiMohammad R, ThangavelJayakumar

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To study usefulness of bone marrow progenitor cells (BPCs) epigenetically altered by chromatin modifying agents in mediating heart repair after myocardial infarction in mice. METHODS AND RESULTS: We tested the therapeutic efficacy of bone marrow progenitor cells treated with the clinical...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142193/

データ提供:米国国立医学図書館(NLM)

Harnessing Epigenetic Modification for Heart Repair

The [heart] is a vital organ, and its health is paramount to our well-being. However, [myocardial infarction], also known as a heart attack, can severely damage this precious organ. Researchers are constantly seeking ways to repair heart damage, and this study investigates the use of epigenetically-modified [bone marrow progenitor cells] to regenerate heart tissue. The study used a mouse model of [myocardial infarction] and evaluated the therapeutic potential of bone marrow progenitor cells treated with the clinically-used chromatin modifying agents Trichostatin A (TSA) and 5Aza-2-deoxycytidine (Aza). These agents were used to induce the expression of pluripotent genes, leading to the differentiation of these cells into cardiomyocyte progenitors and ultimately, heart muscle cells.

Epigenetic Modification Shows Promise for Heart Regeneration

This research suggests that epigenetically-modified [bone marrow progenitor cells] may hold significant potential for heart repair. The authors observed that mice treated with these modified cells showed improved left ventricular function, a key indicator of heart health. This improvement was linked to the differentiation of the injected cells into cardiomyocytes and endothelial cells, demonstrating the regenerative capacity of these cells.

A Glimpse into the Future of Heart Regeneration

This exciting research provides a glimpse into the potential of using epigenetically-modified [bone marrow progenitor cells] for heart regeneration. While more research is needed to translate these findings into clinical applications, this study sheds light on a promising avenue for treating heart damage. The use of these modified cells may one day become a standard treatment for patients who have suffered from a heart attack, offering them a chance for a renewed heart.

Dr.Camel's Conclusion

Just as a camel adapts to the harsh desert environment, researchers are constantly adapting their tools and knowledge to address the challenges of [heart disease]. This research, like a cool oasis in the desert, provides a refreshing glimpse of hope for the future of [heart repair], demonstrating the potential of epigenetic modification to restore the health of this vital organ.

Date :
  1. Date Completed 2011-12-06
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21799893

DOI: Digital Object Identifier

PMC3142193

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.